CJC-1295 no DAC 5mg + Ipamorelin 5mg Combo

CJC-1295 no DAC 5mg + Ipamorelin 5mg Combo (Catalog No. CP5) is a research combination kit supplied by PeptaCo for qualified laboratory applications. Each kit contains matched vials of CJC-1295 no DAC and Ipamorelin (5mg each) in lyophilized powder format. This combination enables investigation of complementary GH release pathways. PeptaCo supplies this kit with batch-specific documentation and COA available upon request.

Cat. No. CP10
Specification 5mg × 10 vials
Form Lyophilized powder
Category Growth Hormone Peptides
Documentation support COA upon request
B2B supply Bulk quotation available
Traceability Batch-specific records

Important Note

This product is intended for qualified laboratory research and analytical applications. It is not for human or veterinary use. Specifications and documentation vary by batch — please contact PeptaCo for the current batch information.

Molecular Profile

What is CJC-1295 + Ipamorelin?

This combination product blends CJC-1295 (without DAC) and Ipamorelin in a single lyophilized format. It is supplied for qualified research investigating combined GHRH/GHRP signaling in laboratory settings.

This listing covers the 5mg × 10 vials configuration under catalog number CP10. Appearance, analytical results, counter-ion information, and other release specifications should be confirmed against the certificate issued for the current batch.

Compound data

Chemical Structure & Purity Profile

Purity >99% Peptide Content >98%
Chemical Structure
CJC-1295 + Ipamorelin chemical structure

PubChem CID 91976842

View CJC-1295 + Ipamorelin PubChem record
TypeCombination kit: CJC-1295 without DAC + Ipamorelin
PubChem CID91976842
HPLC Purity>99% (batch-specific COA available)
Peptide Content>98% peptide content — not just chromatographic purity
DocumentationCurrent batch COA and analytical package available upon request
Why peptide content matters: some suppliers may report high chromatographic purity while delivering lower actual peptide content. PeptaCo specifies both >99% purity and >98% peptide content for qualified B2B supply.

Product Specifications

Product NameCJC-1295 + Ipamorelin
Catalog NumberCP10
Specification5mg × 10 vials
Product FormLyophilized powder
CategoryGrowth Hormone Peptides
DocumentationBatch-specific COA available upon request
StorageRefer to batch-specific product documentation
Intended MarketQualified B2B and research customers

Quality & Analytical Documentation

Batch-specific analytical documentation is available to qualified customers upon request. Contact PeptaCo with the product SKU and required quantity to request the current documentation package.

Identity Confirmation — available by request
Purity Analysis — available by request
Batch Traceability — provided with every order
Additional Testing — product- and batch-dependent

Need Current Batch Documentation or Bulk Pricing?

Tell us the product SKU, quantity, documentation requirements, and destination country. The PeptaCo team will prepare the applicable quotation and document package.

Description

Product Overview

This CJC-1295 + Ipamorelin combination product contains two GH secretagogue research peptides supplied together in a single kit by PeptaCo for qualified laboratory research. CJC-1295 (without DAC) is a GHRH analog, while Ipamorelin is a selective GHS-R agonist. The combination enables researchers to investigate complementary GH release pathways in a single experimental protocol.

Key Product Details

  • Product Name: CJC-1295 no DAC + Ipamorelin Combo
  • Specification: As listed per catalog variant (equal-weight vials of each peptide)
  • Product Form: Lyophilized powder (2 separate vials per kit)
  • Category: GH Secretagogue Research Peptides — Combination Kit
  • Contents: CJC-1295 no DAC vial + Ipamorelin vial (matching specifications)

Chemical Identity

CJC-1295 no DAC (Mod GRF 1-29): 29-amino-acid GHRH analog. MW: ~3366 Da.
Ipamorelin: Pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2). MW: ~712 Da.
This combination kit provides matched vials of each peptide for research into synergistic GH release mechanisms.

Research Context

The CJC-1295 + Ipamorelin combination is widely used in research settings to study synergistic GH release pathways. CJC-1295 acts on GHRH receptors while Ipamorelin selectively targets GHS-R, enabling investigation of complementary signaling mechanisms. PeptaCo supplies this combination in multiple specification levels (2.5mg+2.5mg, 5mg+5mg) to support diverse research scales.

Storage and Handling

Store both vials in a cool, dry place away from direct light. Follow batch-specific storage instructions provided with the certificate of analysis. Avoid repeated freeze-thaw cycles. Handle using standard laboratory practices.

Documentation and Quality

Batch-specific analytical documentation is available to qualified customers upon request. Contact PeptaCo with the product SKU and required quantity to request the current documentation package. Each kit includes documentation for both components, including identity confirmation, purity analysis, and batch traceability records.

Important Notice

This product is supplied for qualified laboratory research and analytical applications only. It is not for human or veterinary use. Product specifications may vary by batch. Appearance, analytical results, counter-ion information, and other release specifications should be confirmed against the certificate issued for the current batch.

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 no DAC 5mg + Ipamorelin 5mg Combo”

Your email address will not be published. Required fields are marked *